4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-020675
CEO and CFO bought 2,300 shares at $9.26 ($21,298)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-10-31 | Purchase | +2,300 | $9.26 | $21,298 | 5,572,902 | D |
| Open-market purchases · 2,300 sh · avg $9.26 · $21,298 | |||||||
Loading xslF345X05/ownership.xml…